Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase

Victor Adler, Wilbur Bowne, Josef Michl, Kelley A. Sookraj, Kamran Ikram, Sidney Pestka, Lara Izotova, Michael Zenilman, Fred K. Friedman, Yongxia Qu, Matthew R. Pincus

Research output: Contribution to journalArticle

Abstract

In a study of interactions between the raf-MEK-MAPK (ERK) and JNK-jun pathways, we found previously that JNK can induce phosphorylation of raf but not vice versa. In this study, we investigate the nature of the JNK-induced phosphorylation of raf. In in vitro experiments in which immuno-bead-bound raf is phosphorylated by activated JNK, we find strong phosphorylation signals at raf-Ser259 and Ser338. The Ser259 phosphorylation is surprising since it is associated with inhibition of migration of raf to the cell membrane where it can interact with ras-p21. We also find that in oocytes induced to mature with oncogenic ras-p21, which induces high levels of phosphorylated JNK and MAPK, the same pattern of phosphorylation of raf occurs. In contrast, in oocytes induced to mature with insulin, which requires activation of wild-type ras-p21, phosphorylation of raf-Ser338 but not raf-Ser259 occurs. In oncogenic ras-transformed human pancreatic cancer MIA-PaCa-2 cells, phosphorylation of both raf serines occurs. Treatment of these cells with the ras peptide, PNC-2 attached to a penetratin sequence that blocks JNK and MAPK phosphorylation and induces tumor cell necrosis, results in a marked decrease in phosphorylation of raf-Ser259, but not that of raf-Ser338. These results suggest that oncogenic ras-p21 induces phosphorylation of both raf-Ser259 and Ser338 and that raf-Ser 259 phosphorylation may be effected by activated JNK.

Original languageEnglish (US)
Pages (from-to)47-56
Number of pages10
JournalAnnals of Clinical and Laboratory Science
Volume38
Issue number1
StatePublished - Dec 2008
Externally publishedYes

Fingerprint

Proto-Oncogene Proteins p21(ras)
Phosphorylation
Phosphotransferases
Oocytes
Cells
MAP Kinase Signaling System
Mitogen-Activated Protein Kinase Kinases
Cell membranes
Pancreatic Neoplasms
Serine
Tumors
Necrosis

Keywords

  • JNK
  • Oncogenic ras-p21
  • Phosphorylation
  • raf
  • raf-Ser259
  • raf-Ser338

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Clinical Biochemistry

Cite this

Adler, V., Bowne, W., Michl, J., Sookraj, K. A., Ikram, K., Pestka, S., ... Pincus, M. R. (2008). Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase. Annals of Clinical and Laboratory Science, 38(1), 47-56.

Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase. / Adler, Victor; Bowne, Wilbur; Michl, Josef; Sookraj, Kelley A.; Ikram, Kamran; Pestka, Sidney; Izotova, Lara; Zenilman, Michael; Friedman, Fred K.; Qu, Yongxia; Pincus, Matthew R.

In: Annals of Clinical and Laboratory Science, Vol. 38, No. 1, 12.2008, p. 47-56.

Research output: Contribution to journalArticle

Adler, V, Bowne, W, Michl, J, Sookraj, KA, Ikram, K, Pestka, S, Izotova, L, Zenilman, M, Friedman, FK, Qu, Y & Pincus, MR 2008, 'Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase', Annals of Clinical and Laboratory Science, vol. 38, no. 1, pp. 47-56.
Adler, Victor ; Bowne, Wilbur ; Michl, Josef ; Sookraj, Kelley A. ; Ikram, Kamran ; Pestka, Sidney ; Izotova, Lara ; Zenilman, Michael ; Friedman, Fred K. ; Qu, Yongxia ; Pincus, Matthew R. / Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase. In: Annals of Clinical and Laboratory Science. 2008 ; Vol. 38, No. 1. pp. 47-56.
@article{be30493a973749af94265c7f4a593360,
title = "Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase",
abstract = "In a study of interactions between the raf-MEK-MAPK (ERK) and JNK-jun pathways, we found previously that JNK can induce phosphorylation of raf but not vice versa. In this study, we investigate the nature of the JNK-induced phosphorylation of raf. In in vitro experiments in which immuno-bead-bound raf is phosphorylated by activated JNK, we find strong phosphorylation signals at raf-Ser259 and Ser338. The Ser259 phosphorylation is surprising since it is associated with inhibition of migration of raf to the cell membrane where it can interact with ras-p21. We also find that in oocytes induced to mature with oncogenic ras-p21, which induces high levels of phosphorylated JNK and MAPK, the same pattern of phosphorylation of raf occurs. In contrast, in oocytes induced to mature with insulin, which requires activation of wild-type ras-p21, phosphorylation of raf-Ser338 but not raf-Ser259 occurs. In oncogenic ras-transformed human pancreatic cancer MIA-PaCa-2 cells, phosphorylation of both raf serines occurs. Treatment of these cells with the ras peptide, PNC-2 attached to a penetratin sequence that blocks JNK and MAPK phosphorylation and induces tumor cell necrosis, results in a marked decrease in phosphorylation of raf-Ser259, but not that of raf-Ser338. These results suggest that oncogenic ras-p21 induces phosphorylation of both raf-Ser259 and Ser338 and that raf-Ser 259 phosphorylation may be effected by activated JNK.",
keywords = "JNK, Oncogenic ras-p21, Phosphorylation, raf, raf-Ser259, raf-Ser338",
author = "Victor Adler and Wilbur Bowne and Josef Michl and Sookraj, {Kelley A.} and Kamran Ikram and Sidney Pestka and Lara Izotova and Michael Zenilman and Friedman, {Fred K.} and Yongxia Qu and Pincus, {Matthew R.}",
year = "2008",
month = "12",
language = "English (US)",
volume = "38",
pages = "47--56",
journal = "Annals of Clinical and Laboratory Science",
issn = "0091-7370",
publisher = "Association of Clinical Scientists",
number = "1",

}

TY - JOUR

T1 - Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase

AU - Adler, Victor

AU - Bowne, Wilbur

AU - Michl, Josef

AU - Sookraj, Kelley A.

AU - Ikram, Kamran

AU - Pestka, Sidney

AU - Izotova, Lara

AU - Zenilman, Michael

AU - Friedman, Fred K.

AU - Qu, Yongxia

AU - Pincus, Matthew R.

PY - 2008/12

Y1 - 2008/12

N2 - In a study of interactions between the raf-MEK-MAPK (ERK) and JNK-jun pathways, we found previously that JNK can induce phosphorylation of raf but not vice versa. In this study, we investigate the nature of the JNK-induced phosphorylation of raf. In in vitro experiments in which immuno-bead-bound raf is phosphorylated by activated JNK, we find strong phosphorylation signals at raf-Ser259 and Ser338. The Ser259 phosphorylation is surprising since it is associated with inhibition of migration of raf to the cell membrane where it can interact with ras-p21. We also find that in oocytes induced to mature with oncogenic ras-p21, which induces high levels of phosphorylated JNK and MAPK, the same pattern of phosphorylation of raf occurs. In contrast, in oocytes induced to mature with insulin, which requires activation of wild-type ras-p21, phosphorylation of raf-Ser338 but not raf-Ser259 occurs. In oncogenic ras-transformed human pancreatic cancer MIA-PaCa-2 cells, phosphorylation of both raf serines occurs. Treatment of these cells with the ras peptide, PNC-2 attached to a penetratin sequence that blocks JNK and MAPK phosphorylation and induces tumor cell necrosis, results in a marked decrease in phosphorylation of raf-Ser259, but not that of raf-Ser338. These results suggest that oncogenic ras-p21 induces phosphorylation of both raf-Ser259 and Ser338 and that raf-Ser 259 phosphorylation may be effected by activated JNK.

AB - In a study of interactions between the raf-MEK-MAPK (ERK) and JNK-jun pathways, we found previously that JNK can induce phosphorylation of raf but not vice versa. In this study, we investigate the nature of the JNK-induced phosphorylation of raf. In in vitro experiments in which immuno-bead-bound raf is phosphorylated by activated JNK, we find strong phosphorylation signals at raf-Ser259 and Ser338. The Ser259 phosphorylation is surprising since it is associated with inhibition of migration of raf to the cell membrane where it can interact with ras-p21. We also find that in oocytes induced to mature with oncogenic ras-p21, which induces high levels of phosphorylated JNK and MAPK, the same pattern of phosphorylation of raf occurs. In contrast, in oocytes induced to mature with insulin, which requires activation of wild-type ras-p21, phosphorylation of raf-Ser338 but not raf-Ser259 occurs. In oncogenic ras-transformed human pancreatic cancer MIA-PaCa-2 cells, phosphorylation of both raf serines occurs. Treatment of these cells with the ras peptide, PNC-2 attached to a penetratin sequence that blocks JNK and MAPK phosphorylation and induces tumor cell necrosis, results in a marked decrease in phosphorylation of raf-Ser259, but not that of raf-Ser338. These results suggest that oncogenic ras-p21 induces phosphorylation of both raf-Ser259 and Ser338 and that raf-Ser 259 phosphorylation may be effected by activated JNK.

KW - JNK

KW - Oncogenic ras-p21

KW - Phosphorylation

KW - raf

KW - raf-Ser259

KW - raf-Ser338

UR - http://www.scopus.com/inward/record.url?scp=40049106639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40049106639&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 47

EP - 56

JO - Annals of Clinical and Laboratory Science

JF - Annals of Clinical and Laboratory Science

SN - 0091-7370

IS - 1

ER -